These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8853559)

  • 1. Acylcarnitine removal in a patient with acyl-CoA beta-oxidation deficiency disorder: effect of L-carnitine therapy and starvation.
    Fontaine M; Briand G; Vallée L; Ricart G; Degand P; Divry P; Vianey-Saban C; Vamecq J
    Clin Chim Acta; 1996 Aug; 252(2):109-22. PubMed ID: 8853559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine.
    Chalmers RA; Roe CR; Stacey TE; Hoppel CL
    Pediatr Res; 1984 Dec; 18(12):1325-8. PubMed ID: 6441143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medium-chain acyl-CoA dehydrogenase deficiency: metabolic effects and therapeutic efficacy of long-term L-carnitine supplementation.
    Treem WR; Stanley CA; Goodman SI
    J Inherit Metab Dis; 1989; 12(2):112-9. PubMed ID: 2502671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary acylcarnitines in a patient with neonatal multiple acyl-CoA dehydrogenation deficiency, quantified by a carboxylic acid analyzer with a reversed-phase column.
    Kidouchi K; Niwa T; Nohara D; Asai K; Sugiyama N; Morishita H; Kobayashi M; Wada Y
    Clin Chim Acta; 1988 Apr; 173(3):263-72. PubMed ID: 3383426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of supplementation with L-carnitine at a small dose on acylcarnitine profiles in serum and urine and the renal handling of acylcarnitines in a patient with multiple acyl-coenzyme A dehydrogenation defect.
    Yoshino M; Tokunaga Y; Watanabe Y; Yoshida I; Sakaguchi M; Hata I; Shigematsu Y; Kimura M; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(1):73-82. PubMed ID: 12828999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary medium-chain acylcarnitines in medium-chain acyl-CoA dehydrogenase deficiency, medium-chain triglyceride feeding and valproic acid therapy: sensitivity and specificity of the radioisotopic exchange/high performance liquid chromatography method.
    Schmidt-Sommerfeld E; Penn D; Rinaldo P; Kossak D; Li BU; Huang ZH; Gage DA
    Pediatr Res; 1992 Jun; 31(6):545-51. PubMed ID: 1635814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic studies in twin brothers with 2-methylacetoacetyl-CoA thiolase deficiency.
    Fontaine M; Briand G; Ser N; Armelin I; Rolland MO; Degand P; Vamecq J
    Clin Chim Acta; 1996 Nov; 255(1):67-83. PubMed ID: 8930414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and quantitation of acylcarnitines in plasma and blood spots from patients with inborn errors of fatty acid oxidation.
    Schmidt-Sommerfeld E; Penn D; Duran M; Rinaldo P; Bennett MJ; Santer R; Stanley CA
    Prog Clin Biol Res; 1992; 375():355-62. PubMed ID: 1438381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
    J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of beta-oxidation intermediates in normal and MCAD-deficient human fibroblasts using tandem mass spectrometry.
    Nada MA; Chace DH; Sprecher H; Roe CR
    Biochem Mol Med; 1995 Feb; 54(1):59-66. PubMed ID: 7551818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early diagnosis and treatment of neonatal medium-chain acyl-CoA dehydrogenase deficiency: report of two siblings.
    Catzeflis C; Bachmann C; Hale DE; Coates PM; Wiesmann U; Colombo JP; Joris F; Délèze G
    Eur J Pediatr; 1990 May; 149(8):577-81. PubMed ID: 2347356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a newborn screening follow-up algorithm for the diagnosis of isobutyryl-CoA dehydrogenase deficiency.
    Oglesbee D; He M; Majumder N; Vockley J; Ahmad A; Angle B; Burton B; Charrow J; Ensenauer R; Ficicioglu CH; Keppen LD; Marsden D; Tortorelli S; Hahn SH; Matern D
    Genet Med; 2007 Feb; 9(2):108-16. PubMed ID: 17304052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic and therapeutic implications of medium-chain acylcarnitines in the medium-chain acyl-coA dehydrogenase deficiency.
    Roe CR; Millington DS; Maltby DA; Bohan TP; Kahler SG; Chalmers RA
    Pediatr Res; 1985 May; 19(5):459-66. PubMed ID: 4000772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carnitine metabolism in the vitamin B-12-deficient rat.
    Brass EP; Stabler SP
    Biochem J; 1988 Oct; 255(1):153-9. PubMed ID: 3196310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acylcarnitines in the urine of a patient with medium chain acyl-CoA dehydrogenase (MCAD) deficiency and in normal children.
    Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL
    Prog Clin Biol Res; 1990; 321():403-9. PubMed ID: 2326301
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
    Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
    J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Carnitine palmitoyltransferase 2 deficiency: the time-course of blood and urinary acylcarnitine levels during initial L-carnitine supplementation.
    Hori T; Fukao T; Kobayashi H; Teramoto T; Takayanagi M; Hasegawa Y; Yasuno T; Yamaguchi S; Kondo N
    Tohoku J Exp Med; 2010 Jul; 221(3):191-5. PubMed ID: 20543534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.